SCOP Search:   
        by sunid, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: All beta proteins (24004)
(-)
Fold: Immunoglobulin-like beta-sandwich (7299)
(-)
Superfamily: Immunoglobulin (5995)
(-)
Family: C1 set domains (antibody constant domain-like) (3013)
(-)
Protein domain: automated matches (652)
(-)
Chimpanzee (Pan troglodytes) [TaxId: 9598] (1)
3UC0L:109-210; M:109-212CRYSTAL STRUCTURE OF DOMAIN I OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2
(-)
Cow (Bos taurus) [TaxId: 9913] (1)
3L9RA:184-278; C:184-278; E:184-278; G:184-278CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS
(-)
Escherichia coli [TaxId: 562] (1)
3TYFA:115-202; B:119-247; C:115-202; D:119-247CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR
(-)
Human (Homo sapiens) [TaxId: 9606] (334)
1TZGL:107-213; M:107-213CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41
1U6AL:108-213CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV FAB F105
1ZA6A:114-220; C:114-220; E:114-220; G:114-220THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
1ZLSL:108-210FAB 2G12 + MAN4
1ZLUK:108-212; L:108-212FAB 2G12 + MAN5
1ZLVK:108-212; L:108-212FAB 2G12 + MAN7
1ZLWK:108-212; L:108-210FAB 2G12 + MAN8
2AGJL:108-215CRYSTAL STRUCTURE OF A GLYCOSYLATED FAB FROM AN IGM CRYOGLOBULIN WITH PROPERTIES OF A NATURAL PROTEOLYTIC ANTIBODY
2AJ3A:108-213; C:108-213; E:108-213CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18
2BC4A:97-200; B:94-193; C:97-206; D:94-199CRYSTAL STRUCTURE OF HLA-DM
2BNUA:116-204STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2CDGA:116-193STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5B)
2CMRL:107-207CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY D5 FAB BOUND TO THE GP41 INNER-CORE MIMETIC 5-HELIX
2D4DA:THE CRYSTAL STRUCTURE OF HUMAN BETA2-MICROGLOBULIN, L39W W60F W95F MUTANT
2EYRA:118-205; B:120-247A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2EYSA:118-205; B:120-247A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2EYTA:118-205; B:120-247; C:118-205; D:120-247A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2FJFA:108-211; C:108-211; E:108-211; G:108-211; J:108-211; L:108-211; M:108-211; O:108-211; Q:108-211; S:108-211; U:108-211; W:108-211STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB
2FJGA:108-211; L:108-211STRUCTURE OF THE G6 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF
2FJHA:107-211; L:107-214STRUCTURE OF THE B20-4 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF
2FSEA:82-181; C:82-180CRYSTALLOGRAPHIC STRUCTURE OF A RHEUMATOID ARTHRITIS MHC SUSCEPTIBILITY ALLELE, HLA-DR1 (DRB1*0101), COMPLEXED WITH THE IMMUNODOMINANT DETERMINANT OF HUMAN TYPE II COLLAGEN
2H9GA:108-211; L:108-211CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5)
2HFFA:107-213; L:107-210CRYSTAL STRUCTURE OF CB2 FAB
2HFGL:107-212CRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB
2IALA:110-198; B:113-240; C:110-198; D:113-240STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2IAMC:110-198; D:113-240STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2IAND:110-198; E:113-240; I:110-198; J:113-240; N:110-198; O:113-240; S:110-198; T:113-240STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2J6EA:236-339; A:340-445; B:238-339; B:340-446; M:109-211CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
2JB5L:113-214FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-1
2JB6A:113-214; L:113-214FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-2
2NW2A:118-206CRYSTAL STRUCTURE OF ELS4 TCR AT 1.4A
2NYYC:112-216CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
2OLDA:113-217; B:113-217BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P3(2)21 CRYSTAL FORM
2OMBA:113-217; B:113-217; C:113-217; D:113-217BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P3(1)21 CRYSTAL FORM
2OMNA:113-217; B:113-217BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P4(3)2(1)2 CRYSTAL FORM
2PYFA:116-205; B:114-241CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY UNBOUND TCR CLONE 5-1
2QQKL:108-211NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
2QQLL:107-214NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
2QQNL:108-214NEUROPILIN-1 B1 DOMAIN IN COMPLEX WITH A VEGF-BLOCKING FAB
2R56L:108-211; M:108-211CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
2VLMD:113-201THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VXQL:108-213CRYSTAL STRUCTURE OF THE MAJOR GRASS POLLEN ALLERGEN PHL P 2 IN COMPLEX WITH ITS SPECIFIC IGE-FAB
2VXSL:109-210; M:109-212; N:109-210; O:109-212STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT, FULLY HUMAN NEUTRALISING ANTIBODY
2VXVL:108-213CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT
2WAHA:238-339; A:340-444; B:237-339; B:340-445CRYSTAL STRUCTURE OF AN IGG1 FC GLYCOFORM (MAN9GLCNAC2)
2WBJB:93-188; C:114-200; F:93-190; G:114-202TCR COMPLEX
2WUBL:108-214; Q:108-214CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON-INHIBITORY ANTIBODY FAB40.DELTATRP
2WUCL:108-214CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON-INHIBITORY ANTIBODY FAB40.DELTATRP AND AC-KQLR-CHLOROMETHYLKETONE
2X89D:; E:; F:; G:STRUCTURE OF THE BETA2_MICROGLOBULIN INVOLVED IN AMYLOIDOGENESIS
2XA8L:112-218CRYSTAL STRUCTURE OF THE FAB DOMAIN OF OMALIZUMAB AT 2.41A
2XKUA:PRION-LIKE CONVERSION DURING AMYLOID FORMATION AT ATOMIC RESOLUTION
2XNAA:112-200CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN T CELL RECEPTOR AND STAPHYLOCOCCAL ENTEROTOXIN
2XPGB:CRYSTAL STRUCTURE OF A MHC CLASS I-PEPTIDE COMPLEX
2XQBL:108-209CRYSTAL STRUCTURE OF ANTI-IL-15 ANTIBODY IN COMPLEX WITH HUMAN IL-15
2XWTB:108-213CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY
2XZAL:110-216CRYSTAL STRUCTURE OF RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
2XZCL:110-216CRYSTAL STRUCTURE OF PHOSPHONATE-MODIFIED RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
2YK1L:108-205STRUCTURE OF HUMAN ANTI-NICOTINE FAB FRAGMENT IN COMPLEX WITH NICOTINE
2YKLL:108-208STRUCTURE OF HUMAN ANTI-NICOTINE FAB FRAGMENT IN COMPLEX WITH NICOTINE-11-YL-METHYL-(4-ETHYLAMINO-4-OXO)-BUTANOATE
3AGVA:241-339; A:340-443; B:237-339; B:340-444CRYSTAL STRUCTURE OF A HUMAN IGG-APTAMER COMPLEX
3BDYL:108-213DUAL SPECIFIC BH1 FAB IN COMPLEX WITH VEGF
3BE1L:108-212DUAL SPECIFIC BH1 FAB IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HER2/ERBB-2
3BN9C:108-210; E:108-211CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
3BQUA:108-211CRYSTAL STRUCTURE OF THE 2F5 FAB'-3H6 FAB COMPLEX
3BZFB:; D:THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
3C08L:107-211CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB/EMD72000 (FAB72000)
3C2SA:236-339; A:340-445STRUCTURAL CHARACTERIZATION OF A HUMAN FC FRAGMENT ENGINEERED FOR LACK OF EFFECTOR FUNCTIONS
3C5JB:93-190CRYSTAL STRUCTURE OF HLA DR52C
3D85A:108-213CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB
3DGGA:111-217; C:111-215CRYSTAL STRUCTURE OF FABOX108
3DIFA:108-213; C:108-214CRYSTAL STRUCTURE OF FABOX117
3DX9A:126-215; B:130-257; C:126-215; D:130-257CRYSTAL STRUCTURE OF THE DM1 TCR AT 2.75A
3EO9L:108-213CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB
3EOAA:108-214; L:108-214CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN, FORM I
3EYOA:109-213; C:109-214CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
3EYQC:109-212CRYSTAL STRUCTURE OF MJ5 FAB, A GERMLINE ANTIBODY VARIANT OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
3F12A:110-212; C:110-214GERMLINE V-GENES SCULPT THE BINDING SITE OF A FAMILY OF ANTIBODIES NEUTRALIZING HUMAN CYTOMEGALOVIRUS
3FJTA:236-339; A:340-444; B:236-339; B:340-444CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE
3FZUD:108-213; L:108-213IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
3G6AA:109-210; L:109-210CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY CNTO607
3G6JE:107-214; G:107-214C3B IN COMPLEX WITH A C3B SPECIFIC FAB
3GBML:108-213; M:112-211CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ.
3GIZL:108-211CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CD20 ANTIBODY OFATUMUMAB
3GJEA:111-212; L:111-212RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
3GKWL:108-207CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NIMOTUZUMAB. AN ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
3GRWL:108-214FGFR3 IN COMPLEX WITH A FAB
3GSNA:112-200; B:117-244; H:182-274CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE
3GSOA:182-274CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV PEPTIDE
3GSQA:182-274CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5S PEPTIDE VARIANT
3GSRA:182-274CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5V PEPTIDE VARIANT
3GSUA:182-275CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5T PEPTIDE VARIANT
3GSVA:182-275CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5Q PEPTIDE VARIANT
3GSWA:182-274CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8A PEPTIDE VARIANT
3GSXA:182-274CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8V PEPTIDE VARIANT
3H0TA:112-216HEPCIDIN-FAB COMPLEX
3H42L:113-214CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH FAB FROM LDLR COMPETITIVE ANTIBODY
3H9YA:336-438; A:439-544; B:335-438; B:439-544; E:336-438; E:439-544CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS
3H9ZA:336-438; A:439-544; B:336-438; B:439-544; C:336-438; C:439-544; D:336-438; D:439-544CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS
3HA0A:336-438; A:439-544; B:336-438; B:439-544; C:336-438; C:439-544; D:336-438; D:439-544; E:336-438; E:439-544; F:336-438; F:439-544CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS
3HC0B:108-213; L:108-212BHA10 IGG1 WILD-TYPE FAB - ANTIBODY DIRECTED AT HUMAN LTBR
3HC3L:108-213BHA10 IGG1 FAB DOUBLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR
3HC4L:108-213BHA10 IGG1 FAB QUADRUPLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR
3HI1A:108-214; L:108-214STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING-SITE ANTIBODY F105
3HI5L:107-211CRYSTAL STRUCTURE OF FAB FRAGMENT OF AL-57
3HI6L:107-211; Y:107-210CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
3HMWL:107-214CRYSTAL STRUCTURE OF USTEKINUMAB FAB
3HMXL:107-214CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX
3HUJE:118-206; F:119-247; G:118-206; H:119-247CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
3IDXL:108-213CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13, SPACE GROUP C222
3INUL:108-211; N:108-211CRYSTAL STRUCTURE OF AN UNBOUND KZ52 NEUTRALIZING ANTI-EBOLAVIRUS ANTIBODY.
3JWDL:108-214; O:108-213STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY
3K2UL:108-214CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC INHIBITORY ANTIBODY FAB40
3KR3L:109-214CRYSTAL STRUCTURE OF IGF-II ANTIBODY COMPLEX
3KYMA:108-213; C:108-213; E:108-213; G:108-213; I:108-213; K:108-212; M:108-208; O:108-213CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB
3L5XL:108-214CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND H2L6 FAB
3L7FA:108-213; D:108-213; L:108-213STRUCTURE OF IL-13 ANTIBODY H2L6, A HUMANIZED VARIANT OF C836
3LMJL:113-215STRUCTURE OF HUMAN ANTI HIV 21C FAB
3LRSB:108-209; D:108-209; F:108-209; L:108-209STRUCTURE OF PG16, AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3LZFL:108-211CRYSTAL STRUCTURE OF FAB 2D1 IN COMPLEX WITH THE 1918 INFLUENZA VIRUS HEMAGGLUTININ
3M1BA:177-267; C:177-267; E:177-267; G:177-267CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR
3M8OL:113-219HUMAN IGA1 FAB FRAGMENT
3MFFA:122-210; B:116-243; C:122-210; D:116-2431F1E8HU TCR
3MLRL:112-213CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A NY5 V3 PEPTIDE
3MLSL:112-213; M:112-213; N:112-213; O:112-213CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV-1 GP120 V3 MIMOTOPE
3MLTA:112-213; D:112-213; G:112-213; L:112-213CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
3MLUL:113-213CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A ZAM18 V3 PEPTIDE
3MLVL:113-213; M:113-213CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE
3MLWL:108-209; M:108-209CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
3MLXL:109-209; M:109-209CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 PEPTIDE
3MLYL:108-211; M:108-211CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A UR29 V3 PEPTIDE
3MLZL:108-211CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A VI191 V3 PEPTIDE
3MUGA:108-212; C:108-212; E:108-212; G:108-212; I:108-212; K:108-213CRYSTAL STRUCTURE OF HUMAN FAB PG16, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3MUHL:108-212CRYSTAL STRUCTURE OF PG9 LIGHT CHAIN
3MXWL:108-212CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT
3N9GL:112-220CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE HUMAN NEUTRALIZING ANTI-WEST NILE VIRUS MAB CR4354
3NA9L:108-214CRYSTAL STRUCTURE OF FAB15
3NAAL:108-214CRYSTAL STRUCTURE OF FAB15 MUT5
3NABL:108-214CRYSTAL STRUCTURE OF FAB15 MUT6
3NACL:108-214CRYSTAL STRUCTURE OF FAB15 MUT7
3NCJL:108-214CRYSTAL STRUCTURE OF FAB15 MUT8
3NFPB:107-212; L:107-212CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
3NFSL:107-212CRYSTAL STRUCTURE THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB
3NPSC:108-212CRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4
3NZHL:108-214CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 5F6 FAB
3O4LD:112-201GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS
3O6FC:111-196; G:111-196CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
3OAYK:108-213; L:108-213A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3OAZK:108-213; L:108-213A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3OB0K:108-213; L:108-212A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3OF6A:120-245; B:120-247; C:120-247HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
3P0VL:108-212; M:108-212ANTI-EGFR/HER3 FAB DL11 ALONE
3P0YL:108-213ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAIN III OF EGFR EXTRACELLULAR REGION
3PGFL:108-214CRYSTAL STRUCTURE OF MALTOSE BOUND MBP WITH A CONFORMATIONALLY SPECIFIC SYNTHETIC ANTIGEN BINDER (SAB)
3PL6B:95-191; C:114-192STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99
3PWPE:118-246THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE
3Q6FA:108-211; C:108-211; E:108-211; G:108-211; I:108-211; K:108-211CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
3QDGD:111-199; E:118-245THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
3QDJD:111-199; E:118-245THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QDMD:110-196; E:116-243THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE
3QEGL:108-212CRYSTAL STRUCTURE OF HUMAN N12-I2 FAB, AN ADCC AND NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY
3QEHB:107-210; D:107-210; F:107-210; H:107-210CRYSTAL STRUCTURE OF HUMAN N12-I15, AN ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY
3QEQD:110-195THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QEUA:111-201; B:118-241; D:111-201; E:118-245THE CRYSTAL STRUCTURE OF TCR DMF5
3QFJE:118-246THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
3QH3A:112-194; B:117-245; C:112-194; D:117-245THE CRYSTAL STRUCTURE OF TCR A6
3QHFL:108-213CRYSTAL STRUCTURE OF FAB DEL2D1, A DELETION VARIANT OF ANTI-INFLUENZA ANTIBODY 2D1
3QHZL:108-215; M:108-212CRYSTAL STRUCTURE OF HUMAN ANTI-INFLUENZA FAB 2D1
3QIBC:112-201CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH MCC/I-EK
3QNXA:113-219ORTHORHOMBIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG
3QNYA:113-219; C:113-219MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG
3QO1A:113-219MONOCLINIC FORM OF IGG1 FAB FRAGMENT (APO FORM) SHARING SAME FV AS IGA
3QOS  [entry was replaced by entry 5I1D without any SCOP domain information]
3QOT  [entry was replaced by entry 5I18 without any SCOP domain information]
3QPQC:108-215; E:108-215; I:108-215; L:108-215CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
3QPXL:107-213CRYSTAL STRUCTURE OF FAB C2507
3QQ9C:112-217; L:112-217CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
3QRGL:112-217CRYSTAL STRUCTURE OF ANTIRSVF FAB B21M
3R1GL:108-214STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE-BINDING ANTIBODY
3REVA:118-205; B:116-242CRYSTAL STRUCTURE OF HUMAN ALLOREACTIVE TCR NB20
3RPIB:97-202; L:97-202CRYSTAL STRUCTURE OF FAB FROM 3BNC60, HIGHLY POTENT ANTI-HIV ANTIBODY
3S7GA:236-339; A:340-443; B:236-339; B:340-442; C:237-339; C:340-444; D:238-339; D:340-444AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
3SDXE:115-203; G:115-203CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
3SDYL:108-214CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8020 BOUND TO THE INFLUENZA A H3 HEMAGGLUTININ
3SE8L:108-213CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC03 IN COMPLEX WITH HIV-1 GP120
3SE9L:108-214CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-PG04 IN COMPLEX WITH HIV-1 GP120
3SKJL:108-214; M:108-214STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY
3SKNA:125-214; B:127-255; C:125-214; D:127-255; E:125-214; F:127-255; G:125-214; H:127-255CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
3SO3B:108-213STRUCTURES OF FAB-PROTEASE COMPLEXES REVEAL A HIGHLY SPECIFIC NON-CANONICAL MECHANISM OF INHIBITION.
3T2NL:109-209; M:109-210HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
3TCLB:108-213; L:108-213CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY CH04
3THML:112-214CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB EP6B_B01
3TJEL:112-213CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB E09
3TNMB:108-208; L:108-208CRYSTAL STRUCTURE OF A32 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY
3TNNB:109-210; D:109-210; F:109-210; L:109-210CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.
3TO4C:118-207; D:122-247STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
3TV3L:108-211CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH MAN9
3TWCL:108-214CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT127 IN COMPLEX WITH MAN9
3TZVA:115-200; G:115-203CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D-LYSOPHOSPHATIDYLCHOLINE
3U2SB:108-208; L:108-208CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109
3U30B:108-211; E:108-211CRYSTAL STRUCTURE OF A LINEAR-SPECIFIC UBIQUITIN FAB BOUND TO LINEAR UBIQUITIN
3U46B:108-213; L:108-213CH04H/CH02L P212121
3U4BL:108-213CH04H/CH02L FAB P4
3U4EB:108-209; L:108-210CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45
3UTPD:113-200; E:118-246; K:113-202; L:118-2461E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA
3V7MA:236-339; A:340-444CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) IN THE PRESENCE OF ZN2+
3VWJC:118-206TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
3VWKC:118-204; D:119-246TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4'DEOXY-ALPHA-GALACTOSYLCERAMIDE COMPLEX
3VXQA:114-204; D:114-204H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
3VXTA:112-200; C:112-200T36-5 TCR SPECIFIC FOR HLA-A24-NEF134-10
3W9DB:108-212; D:108-213STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB
3W9EB:108-211STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB COMPLEX WITH HSV-2 GD
3WD5L:107-213CRYSTAL STRUCTURE OF TNFALPHA IN COMPLEX WITH ADALIMUMAB FAB FRAGMENT
3ZL4L:111-216ANTIBODY STRUCTURAL ORGANIZATION: ROLE OF KAPPA - LAMBDA CHAIN CONSTANT DOMAIN SWITCH IN CATALYTIC FUNCTIONALITY
4AENB:93-190HLA-DR1 WITH COVALENTLY LINKED CLIP106-120 IN REVERSED ORIENTATION
4AL8L:108-213STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
4AM0B:108-212; D:108-212; F:108-212; L:108-212STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
4B7IA:237-339; A:340-444; B:238-339; B:340-444CRYSTAL STRUCTURE OF HUMAN IGG FC BEARING HYBRID-TYPE GLYCANS
4D9LL:109-209; M:109-210; N:109-210; O:109-210FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697
4D9QD:108-213; L:108-213INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
4D9RD:108-213; L:108-214INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
4DKFL:107-212; M:107-208CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2
4DN3L:109-214CRYSTAL STRUCTURE OF ANTI-MCP-1 ANTIBODY CNTO888
4DQOL:108-210CRYSTAL STRUCTURE OF PG16 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109
4DTGL:112-219HEMOSTATIC EFFECT OF A MONOCLONAL ANTIBODY MAB 2021 BLOCKING THE INTERACTION BETWEEN FXA AND TFPI IN A RABBIT HEMOPHILIA MODEL
4DZBA:111-199; B:118-245MUCOSAL-ASSOCIATED INVARIANT T CELL RECEPTOR, VALPHA7.2JALPHA33-VBETA2
4E41D:111-199; E:111-238; I:111-198; J:111-238STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
4E42A:111-198; B:111-238; C:111-198; D:111-238STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
4EDWL:108-214NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM HUMANIZED VERSION OF MOUSE MAB 911 (TANEZUMAB)
4EN3A:114-201CRYSTAL STRUCTURE OF A HUMAN VALPHA24(-) NKT TCR IN COMPLEX WITH CD1D/ALPHA-GALACTOSYLCERAMIDE
4EOWL:112-212CRYSTAL STRUCTURE OF A DISEASE-ASSOCIATED ANTI-HUMAN GM-CSF AUTOANTIBODY MB007
4ERSL:107-214A MOLECULAR BASIS FOR NEGATIVE REGULATION OF THE GLUCAGON RECEPTOR
4EVNB:113-215; D:113-215; F:113-215; H:113-215; J:113-215; L:113-215; N:113-215; P:113-215CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE-REVERTED LIGHT CHAIN)
4F57L:109-209FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L1 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
4F58L:109-209; M:109-209; N:109-209; O:109-209FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
4FNLL:107-213; M:107-213CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
4FP8L:107-213; M:107-213; N:107-213; O:107-213CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ, HA1 SUBUNIT
4FQ2L:109-212CRYSTAL STRUCTURE OF 10-1074 FAB
4FQHB:108-209; L:108-209CRYSTAL STRUCTURE OF FAB CR9114
4FQIL:108-208CRYSTAL STRUCTURE OF FAB CR9114 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ
4FQJL:108-211INFLUENZA B/FLORIDA/4/2006 HEMAGGLUTININ FAB CR8071 COMPLEX
4FQLL:108-214INFLUENZA B HA ANTIBODY (FAB) CR8033
4FQQA:109-210; C:109-209; E:109-209; L:109-212CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB
4FQXB:93-190; C:97-200; D:94-193CRYSTAL STRUCTURE OF HLA-DM BOUND TO HLA-DR1
4FZ8L:108-211CRYSTAL STRUCTURE OF C11 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY.
4FZEL:108-210CRYSTAL STRUCTURE OF N26_I1 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY.
4G3YL:108-214CRYSTAL STRUCTURE OF TNF-ALPHA IN COMPLEX WITH INFLIXIMAB FAB FRAGMENT
4G7VL:108-211CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E, 2.5 A)
4G7YL:108-211CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E, 2.8 A)
4G8EA:128-217; B:135-262CRYSTAL STRUCTURE OF CLONE18 TCR
4G8FA:129-205; B:128-256CRYSTAL STRUCTURE OF CLONE42 TCR
4GKZA:116-201; B:115-242HA1.7, A MHC CLASS II RESTRICTED TCR SPECIFIC FOR HAEMAGGLUTININ
4GRLA:82-180; B:95-191; C:114-192CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX
4GRMA:118-194; B:118-246; C:118-193; D:118-245THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
4GSDL:109-211H5.3 FAB STRUCTURE
4GT7A:334-438; A:439-545; B:333-438; B:439-545; C:332-438; C:439-545; D:333-438; D:439-545AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION
4GW4B:97-199; L:97-198CRYSTAL STRUCTURE OF 3BNC60 FAB WITH P61A MUTATION
4GXVL:108-209; M:108-209CRYSTAL STRUCTURE OF ANTI-INFLUENZA VIRUS ANTIBODY 1F1
4H25B:93-190; E:93-190TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHTS TO NICKEL CONTACT ALLERGY
4H26B:93-190; E:93-190TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHT TO NICKEL CONTACT ALLERGY
4H8WL:109-209CRYSTAL STRUCTURE OF NON-NEUTRALIZING AND ADCC-POTENT ANTIBODY N5-I5 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND SCD4.
4HCRL:112-218; N:112-218CRYSTAL STRUCTURE OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB PF-547659
4HF5L:108-208CRYSTAL STRUCTURE OF FAB 8F8 IN COMPLEX A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4HFUL:107-212CRYSTAL STRUCTURE OF FAB 8M2 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4HFWA:107-211; L:107-212ANTI ROTAVIRUS ANTIBODY
4HH9A:108-214; C:108-214ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5
4HJGA:108-214MEDITOPE-ENABLED TRASTUZUMAB
4HK0B:110-210; D:110-210UCA FAB (UNBOUND) FROM CH65-CH67 LINEAGE
4HK3N:110-210I2 FAB (UNBOUND) FROM CH65-CH67 LINEAGE
4HKXB:110-211INFLUENZA HEMAGGLUTININ IN COMPLEX WITH CH67 FAB
4HKZA:108-213TRASTUZUMAB FAB COMPLEXED WITH PROTEIN L AND PROTEIN A FRAGMENTS
4HQQL:108-208CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58
4HWEL:105-210CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
4I2XA:108-214; C:108-214CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
4I3RL:107-214CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P3221
4I3SL:108-214CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P21
4I77L:108-214LEBRIKIZUMAB FAB BOUND TO IL-13
4IIQA:111-201; B:117-244CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH BOVINE MR1
4IOIA:108-214MEDITOPE-ENABLED TRASTUZUMAB IN COMPLEX WITH CQFDLSTRRLKC
4IRJC:116-204STRUCTURE OF THE MOUSE CD1D-4CLPHC-ALPHA-GALCER-INKT TCR COMPLEX
4J12A:236-339; A:340-444MONOMERIC FC
4J4PD:131-233; L:131-233THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS
4J6RL:108-214CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC23 IN COMPLEX WITH HIV-1 GP120
4JAMB:108-209; L:108-209CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY CH103
4JANB:106-207; L:106-207CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
4JB9L:103-209CRYSTAL STRUCTURE OF ANTIBODY VRC06 IN COMPLEX WITH HIV-1 GP120 CORE
4JDVB:104-209; L:104-209CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF NIH45-46 FAB
4JFHD:111-200; E:117-244HIGH AFFINITY ALPHA24-BETA17 T CELL RECEPTOR FOR A2 HLA-MELANOMA PEPTIDE COMPLEX
4JFXA:108-214; L:108-214STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE
4JFYA:108-211; L:108-213APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD
4JFZL:108-214STRUCTURE OF PHOSPHOSERINE (PSAB) SCAFFOLD BOUND TO PSER PEPTIDE
4JG0L:108-214STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PSER PEPTIDE
4JG1L:108-214STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PTHR PEPTIDE
4JHAL:108-211CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
4JM2B:107-214; C:110-212CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
4JM4L:108-214CRYSTAL STRUCTURE OF PGT 135 FAB
4JPIB:110-214; L:110-213CRYSTAL STRUCTURE OF A PUTATIVE VRC01 GERMLINE PRECURSOR FAB
4JPKL:110-214CRYSTAL STRUCTURE OF THE GERMLINE-TARGETING HIV-1 GP120 ENGINEERED OUTER DOMAIN EOD-GT6 IN COMPLEX WITH A PUTATIVE VRC01 GERMLINE PRECURSOR FAB
4JPVL:108-212CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 3BNC117 IN COMPLEX WITH HIV-1 GP120
4JPWL:108-212CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 12A21 IN COMPLEX WITH HIV-1 STRAIN 93TH057 GP120 MUTANT
4JY5L:109-209CRYSTAL STRUCTURE OF HUMAN FAB PGT122, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4K71B:177-268; E:177-268CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR
4K7PX:108-214GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
4KMTL:108-214CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY 5-51/O12
4KQ3L:107-211CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO3186
4KVNL:107-212CRYSTAL STRUCTURE OF FAB 39.29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/PERTH/16/2009 (H3N2)
4KY1L:108-213HUMANIZED HP1/2 FAB
4L4TD:111-200; G:111-199STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
4L4VD:111-200; G:111-198STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
4L8SA:111-200CRYSTAL STRUCTURE OF A HUMAN VALPHA7.2/VBETA13.3 MAIT TCR IN COMPLEX WITH BOVINE MR1
4LCWD:111-200; G:111-198THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
4LFHG:126-238CRYSTAL STRUCTURE OF 9C2 TCR
4LHUG:126-236CRYSTAL STRUCTURE OF 9C2 TCR BOUND TO CD1D
4LKCA:109-214AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO
4LMQI:108-214; L:108-214DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
4LSPL:108-212CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057
4LSQL:108-213CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057 WITH LOOP D AND LOOP V5 FROM CLADE A STRAIN 3415_V1_C1
4LSUL:108-211CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-PG20 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
4M6ML:113-216CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5
4M6OL:108-214CRYSTAL STRUCTURE OF ANTI-NGF ANTIBODY CNTO7309
4MAYA:82-180; B:95-191; C:114-192CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX
4MNGA:184-278; C:184-278STRUCTURE OF THE DP10.7 TCR WITH CD1D-SULFATIDE
4MWFB:108-213; L:108-213STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
4NDMA:119-246; B:122-212STRUCTURE OF THE AB18.1 TCR
4NM4L:108-213; M:108-213CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043
4NRZB:108-212; L:108-213CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6
4NZRL:108-214CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-HIV ANTIBODY PGT135 FAB
4NZTL:108-212CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-INFLEUNZA HEMAGGLUTININ ANTIBODY CR9114 FAB
4NZUL:108-211CRYSTAL STRUCTURE OF THE PRIMARY MONOCLONAL ANTIBODY 13PL FAB' FROM A MULTIPLE MYELOMA PATIENT
4OAWC:108-214FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158
4OCSL:108-209CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.10, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4OD1L:108-208CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.03, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4OD3L:108-209CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.07, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4PS4L:107-213CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND M1295 FAB
(-)
Mouse (Mus musculus) [TaxId: 10090] (309)
1SEQL:107-211FAB MNAC13
1T2QL:115-218THE CRYSTAL STRUCTURE OF AN NNA7 FAB THAT RECOGNIZES AN N-TYPE BLOOD GROUP ANTIGEN
1UYWL:108-212; N:108-211CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
1WC7A:108-214; L:108-213FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE
1WCBA:108-214; L:108-214PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
1XGPA:108-214STRUCTURE FOR ANTIBODY HYHEL-63 Y33A MUTANT COMPLEXED WITH HEN EGG LYSOZYME
1XGQA:108-214STRUCTURE FOR ANTIBODY HYHEL-63 Y33V MUTANT COMPLEXED WITH HEN EGG LYSOZYME
1XGRA:108-214STRUCTURE FOR ANTIBODY HYHEL-63 Y33I MUTANT COMPLEXED WITH HEN EGG LYSOZYME
1XGTA:108-214STRUCTURE FOR ANTIBODY HYHEL-63 Y33L MUTANT COMPLEXED WITH HEN EGG LYSOZYME
1YJDL:108-212CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)
1YNTA:108-213; C:1108-1213STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
1YQVL:108-212THE CRYSTAL STRUCTURE OF THE ANTIBODY FAB HYHEL5 COMPLEX WITH LYSOZYME AT 1.7A RESOLUTION
1ZTXL:108-212WEST NILE VIRUS ENVELOPE PROTEIN DIII IN COMPLEX WITH NEUTRALIZING E16 ANTIBODY FAB
2A6JA:108-214; L:108-214CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65
2ADFL:107-209CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3, AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN
2ADGA:108-211CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425
2ADIA:108-211CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH BARIUM
2ADJA:108-211CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH CALCIUM
2AJSL:108-211CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH HEPTAETHYLENE GLYCOL
2AJUL:108-211CYRSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB'
2AJVL:108-211CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH COCAINE
2AJXL:108-211CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH TRANSITION STATE ANALOG
2AJYL:108-211CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH ECGONINE METHYL ESTER AND BENZOIC ACID
2AJZA:108-211; L:108-211CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH ECGONINE METHYL ESTER
2AK1L:108-211CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH BENZOIC ACID
2B2XL:115-215; M:115-215VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB
2BMKA:108-214; L:108-214FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE
2BOCB:108-212POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS)
2C1PA:108-213; L:108-213FAB-FRAGMENT OF ENANTIOSELECTIVE ANTIBODY COMPLEXED WITH FINROZOLE
2DDQL:113-218CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A R310 ANTIBODY COMPLEXED WITH (R)-HNE-HISTIDINE ADDUCT
2DQTL:108-214HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG
2DQUL:108-214CRYSTAL FORM II: HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG
2DTML:108-213THERMODYNAMIC AND STRUCTURAL ANALYSES OF HYDROLYTIC MECHANISM BY CATALYTIC ANTIBODIES
2EH7L:108-214CRYSTAL STRUCTURE OF HUMANIZED KR127 FAB
2EXYD:107-211; F:107-211CRYSTAL STRUCTURE OF THE E148Q MUTANT OF ECCLC, FAB COMPLEXED IN ABSENCE OF BOUND IONS
2FATL:107-213AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE
2FSEB:93-190; D:93-189CRYSTALLOGRAPHIC STRUCTURE OF A RHEUMATOID ARTHRITIS MHC SUSCEPTIBILITY ALLELE, HLA-DR1 (DRB1*0101), COMPLEXED WITH THE IMMUNODOMINANT DETERMINANT OF HUMAN TYPE II COLLAGEN
2G2RA:108-214; L:108-214GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE)
2GCYA:111-216HUMANIZED ANTIBODY C25 FAB FRAGMENT
2H2PD:107-211; F:107-211CRYSTAL STRUCTURE OF CLC-EC1 IN COMPLEX WITH FAB FRAGMENT IN SECN-
2H2SD:107-211; F:107-211CRYSTAL STRUCTURE OF E148A MUTANT OF CLC-EC1 IN SECN-
2HKHL:113-219CRYSTAL STRUCTURE OF THE FAB M75
2I9LA:113-219; C:113-219; E:113-219; G:113-219STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
2IPTL:107-213PFA1 FAB FRAGMENT
2IQ9L:107-213PFA2 FAB FRAGMENT, TRICLINIC APO FORM
2IQAA:107-213; L:107-213PFA2 FAB FRAGMENT, MONOCLINIC APO FORM
2J4WL:108-214STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX
2J5LB:108-214STRUCTURE OF A PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX
2NR6C:108-211; E:108-211CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
2NTFA:109-211; L:109-211CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N-ACYL-L-HOMOSERINE LACTONE ANALOG
2OP4L:109-212CRYSTAL STRUCTURE OF QUORUM-QUENCHING ANTIBODY 1G9
2ORBL:108-212; M:108-213THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT
2OZ4L:108-214STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
2Q8AL:108-214STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH-INHIBITORY ANTIBODY
2Q8BL:108-213STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH-INHIBITORY ANTIBODY
2R0WL:107-213PFA2 FAB COMPLEXED WITH ABETA1-8
2R0ZL:107-213PFA1 FAB COMPLEXED WITH GRIPI PEPTIDE FRAGMENT
2R29L:112-213NEUTRALIZATION OF DENGUE VIRUS BY A SEROTYPE CROSS-REACTIVE ANTIBODY ELUCIDATED BY CRYOELECTRON MICROSCOPY AND X-RAY CRYSTALLOGRAPHY
2R9HD:107-211; F:107-211CRYSTAL STRUCTURE OF Q207C MUTANT OF CLC-EC1 IN COMPLEX WITH FAB
2UYLA:113-218; M:113-216; V:113-216; X:113-216CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2V17L:108-214STRUCTURE OF THE COMPLEX OF ANTIBODY MN423 WITH A FRAGMENT OF TAU PROTEIN
2V7HA:108-214; L:108-214CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI-MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT
2VC2L:108-214RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758
2VDKL:108-214RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
2VDLL:108-214RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
2VDML:108-214RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN
2VDNL:108-214RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE
2VL5B:112-217; D:112-216STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2VQ1A:108-212; E:108-212ANTI TRIMERIC LEWIS X FAB54-5C10-A
2VXTL:108-213CRYSTAL STRUCTURE OF HUMAN IL-18 COMPLEXED TO MURINE REFERENCE ANTIBODY 125-2H FAB
2VXUL:108-214; M:108-214CRYSTAL STRUCTURE OF MURINE REFERENCE ANTIBODY 125-2H FAB FRAGMENT
2W60B:113-217ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4
2W9DL:107-211STRUCTURE OF FAB FRAGMENT OF THE ICSM 18 - ANTI-PRP THERAPEUTIC ANTIBODY AT 1.57 A RESOLUTION.
2W9EL:110-212STRUCTURE OF ICSM 18 (ANTI-PRP THERAPEUTIC ANTIBODY) FAB FRAGMENT COMPLEXED WITH HUMAN PRP FRAGMENT 119-231
2XKNA:108-213; C:108-213CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7
2XQYK:108-214; L:108-214CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
2YPVL:108-212CRYSTAL STRUCTURE OF THE MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN IN COMPLEX WITH A BACTERICIDAL ANTIBODY
2Z4QA:113-219CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528
2Z91B:108-212; D:108-213CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
2Z92B:108-211CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C_ABCDE
2ZCHL:108-211CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY
3ARBC:118-207; D:119-247TERNARY CRYSTAL STRUCTURE OF THE NKT TCR-CD1D-ALPHA-GALACTOSYLCERAMIDE ANALOGUE-OCH
3ARDC:118-207TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-3'DEOXY-ALPHA-GALACTOSYLCERAMIDE
3AREC:118-207; D:119-247TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-4'DEOXY-ALPHA-GALACTOSYLCERAMIDE
3ARFC:118-207; D:119-247TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-C20:2
3ARGC:118-207TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA-GLUCOSYLCERAMIDE(C20:2)
3AU1A:186-279CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH GANGLIOSIDE GD3
3AXLA:130-218; B:130-256; G:130-218; H:130-256MURINE VALPHA 10 VBETA 8.1 T-CELL RECEPTOR
3BGFC:108-211; L:108-212X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB
3BT2L:107-212STRUCTURE OF UROKINASE RECEPTOR, UROKINASE AND VITRONECTIN COMPLEX
3BZ4A:108-211; C:108-213; E:108-211; G:108-211CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE
3C5SA:108-213; C:108-212CRYSTAL STRUCTURE OF MONOCLONAL FAB F22-4 SPECIFIC FOR SHIGELLA FLEXNERI 2A O-AG
3C5ZA:113-202; B:113-240; E:113-201; F:113-240CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
3C60A:112-201; B:112-236; E:112-201; F:112-236CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
3C6SA:108-211; C:108-213; E:108-211; G:108-211CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE
3CFBA:108-213; L:108-213HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K
3CFCL:108-214HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2
3CFDA:108-213; L:108-213PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN
3CFEA:108-213; L:108-213CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10
3CLEL:108-212HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
3CLFL:108-214HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
3CMOL:108-211; X:108-211HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18
3CVHL:107-209; R:107-209HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
3CVIL:107-209HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
3D9AL:108-213HIGH RESOLUTION CRYSTAL STRUCTURE STRUCTURE OF HYHEL10 FAB COMPLEXED TO HEN EGG LYSOZYME
3E8UL:108-212CRYSTAL STRUCTURE AND THERMODYNAMIC ANALYSIS OF DIAGNOSTIC FAB 106.3 COMPLEXED WITH BNP 5-13 (C10A) REVEAL BASIS OF SELECTIVE MOLECULAR RECOGNITION
3EFDL:108-211THE CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF KCSA
3EO0A:109-215; C:109-215STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008
3EO1A:108-215; D:108-215; G:108-215; J:108-215STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
3EOTL:112-214CRYSTAL STRUCTURE OF LAC031, AN ENGINEERED ANTI-VLA1 FAB
3FB6B:108-212KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 16 A OPENING AT T112
3FO9A:108-214; L:108-214CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB' IN COMPLEX WITH HAPTEN 1,3-DIKETONE
3G08A:186-279CRYSTAL STRUCTURE OF THE ALPHA-GALACTOSYLCERAMIDE ANALOG OCH IN COMPLEX WITH MOUSE CD1D
3G5XA:108-214; C:108-214ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
3G5ZA:111-213ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
3GI8L:114-220CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
3GI9L:114-219CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
3GNML:113-217THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT
3HE6C:118-208; D:119-247CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA8.2 NKT TCR
3HE7C:118-207CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA7 NKT TCR
3HKFA:241-344; A:345-445MURINE UNGLYCOSYLATED IGG FC FRAGMENT
3HNSL:108-214CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE
3HNTL:108-214CS-35 FAB COMPLEX WITH A LINEAR, TERMINAL OLIGOARABINOFURANOSYL TETRASACCHARIDE FROM LIPOARABINOMANNAN
3HNVL:108-214CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL TETRASACCHARIDE (BRANCH PART OF HEXASACCHARIDE)
3HZKA:107-212CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO
3HZMA:107-212CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO
3HZVA:107-212CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.8) KDO(2.4)KDO
3HZYA:107-210CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3I02A:107-213; C:107-207CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3I2CL:112-218CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO4088
3I50L:108-208CRYSTAL STRUCTURE OF THE WEST NILE VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE E53 ANTIBODY FAB
3I75A:108-212ANTIBODY STRUCTURE
3I9GL:108-213CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE
3IETA:108-212; C:108-213CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN
3IJHA:107-212; C:107-212STRUCTURE OF S67-27 IN COMPLEX WITH KO
3IJSA:107-212; C:107-211STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
3IJYA:107-210; C:107-212STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
3IKCA:107-212; C:107-212STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
3ILPA:186-279STRUCTURE OF MCD1D WITH BOUND GLYCOLIPID BBGL-2F FROM BORRELIA BURGDORFERI
3ILQC:186-279STRUCTURE OF MCD1D WITH BOUND GLYCOLIPID BBGL-2C FROM BORRELIA BURGDORFERI
3IU4L:108-213ANTI NEUGCGM3 GANGLIOSIDE CHIMERIC ANTIBODY CHP3
3IVKB:109-213; L:109-213CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT
3IXTB:108-211; L:108-212CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
3KJ4B:113-219; L:113-219STRUCTURE OF RAT NOGO RECEPTOR BOUND TO 1D9 ANTAGONIST ANTIBODY
3L1OL:108-214CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE, CRYSTALLIZED IN THE PRESENCE OF ZINC
3L5WA:108-213; L:108-213CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
3L7EA:108-213; L:108-213CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
3LIZL:108-211CRYSTAL STRUCTURE OF BLA G 2 COMPLEXED WITH FAB 4C3
3LS4L:109-215CRYSTAL STRUCTURE OF ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT IN COMPLEX WITH THC
3LS5L:109-215ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT, FREE FORM
3MA7A:186-279; C:186-279CRYSTAL STRUCTURE OF CARDIOLIPIN BOUND TO MOUSE CD1D
3MBXL:114-220CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY X836
3MCKA:113-219; L:113-219CRYSTAL STRUCTURE OF ANTI-BETA-AMYLOID ANTIBODY C705
3MCLL:106-209ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP P21
3MXVL:108-212CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA
3NIDF:108-214; L:108-214THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3NIFF:108-214; L:108-214THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3NIGF:108-214; L:108-214THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3NZ8B:108-212; L:108-213CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
3O0RL:108-213CRYSTAL STRUCTURE OF NITRIC OXIDE REDUCTASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
3O11A:106-212; L:106-212ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP C2
3O2DL:107-210CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY
3O6KL:113-217CRYSTAL STRUCTURE OF ANTI-TAT HIV FAB'11H6H1
3O8XA:186-279; C:118-206; D:113-240RECOGNITION OF GLYCOLIPID ANTIGEN BY INKT CELL TCR
3O9WA:186-279; C:118-206; D:113-240RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR
3OJDA:108-214ANTI-INDOLICIDIN MONOCLONAL ANTIBODY V2D2 (FAB FRAGMENT)
3OKDA:108-214CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO
3OKEA:108-212CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KO
3OKKA:108-215CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO
3OKLA:108-214CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO
3OKMA:108-214CRYSTAL STRUCTURE OF UNLIGANDED S25-39
3OKNA:108-213CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO(2.4)KDO
3OKOA:108-212CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO
3OZ9L:111-213CRYSTAL STRUCTURE OF ANTI-GP41 FAB NC-1
3PHOA:111-217CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP
3PHQA:111-217CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH KDO
3PP3K:113-219; L:113-219EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES
3Q3GA:114-220; C:114-220; F:114-220; J:114-220CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3Q5TA:116-240V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
3Q5YA:118-247; B:118-246; C:118-247; D:118-246V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
3QA3A:121-220; C:121-220; F:121-220; J:121-220CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3QG7L:108-211STRUCTURAL BASIS FOR LIGAND RECOGNITION AND DISCRIMINATION OF A QUORUM QUENCHING ANTIBODY
3QI9C:118-204; D:119-243CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR
3QIBA:82-180; B:94-186; D:117-243CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH MCC/I-EK
3QIUA:82-181; B:93-186; C:110-186; D:117-243CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC/I-EK
3QJFA:112-201; C:112-199CRYSTAL STRUCTURE OF THE 2B4 TCR
3QJHA:118-206; B:120-247; C:118-206; D:120-246THE CRYSTAL STRUCTURE OF THE 5C.C7 TCR
3QUXA:186-279; C:118-206STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX
3QUYA:186-279; C:118-206STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1'-INKT TCR COMPLEX
3QUZA:186-279; C:118-206STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX
3QWOB:108-211; L:108-211CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
3RA7L:108-211; M:108-211BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY
3RAJL:106-208CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY HB7
3RGVA:111-200; B:113-236A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS
3RKDC:108-213; L:108-213HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3RTQA:186-279STRUCTURE OF THE MOUSE CD1D-HS44-INKT TCR COMPLEX
3RUGA:186-296; C:186-295; E:130-218; F:129-256; G:130-218; H:129-256CRYSTAL STRUCTURE OF VALPHA10-VBETA8.1 NKT TCR IN COMPLEX WITH CD1D-ALPHAGLUCOSYLCERAMIDE (C20:2)
3RVTC:111-213STRUCTURE OF 4C1 FAB IN P212121 SPACE GROUP
3RVUC:111-212STRUCTURE OF 4C1 FAB IN C2221 SPACE GROUP
3RVV  [entry was replaced by entry 5VPL without any SCOP domain information]
3RVW  [entry was replaced by entry 5VPG without any SCOP domain information]
3RVX  [entry was replaced by entry 5VPH without any SCOP domain information]
3RZCA:186-279STRUCTURE OF THE SELF-ANTIGEN IGB3 BOUND TO MOUSE CD1D AND IN COMPLEX WITH THE INKT TCR
3S34L:108-214STRUCTURE OF THE 1121B FAB FRAGMENT
3S35L:112-217STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES
3S37L:108-213STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES
3SCMC:118-204; D:119-243CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE
3SDAA:186-295; C:118-204; D:119-243CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
3SDCC:118-204; D:120-243CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE
3SDDC:118-203; D:120-242CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE
3SGDI:113-218; L:113-218CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2
3SGEI:113-219; L:113-219CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE
3T1FA:186-279CRYSTAL STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2 COMPLEX
3T3MF:108-214; L:108-214A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
3T3PF:108-214; L:108-214A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
3TA3A:186-279; C:118-206; D:113-240STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2-INKT TCR COMPLEX
3TT1L:112-215; M:112-215CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
3TVMA:186-279; C:118-206; D:113-240; E:186-249; G:118-206; H:113-240STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX
3U0WL:108-213AD RELATED MURINE ANTIBODY FRAGMENT
3UBXI:108-214; L:108-214CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
3UJTL:108-211; M:108-211STRUCTURE OF THE FAB FRAGMENT OF AB-52, AN ANTIBODY THAT BINDS THE O-ANTIGEN OF FRANCISELLA TULARENSIS
3V0VB:108-212; L:108-212FAB WN1 222-5 UNLIGANDED
3V0WL:108-211CRYSTAL STRUCTURE OF FAB WN1 222-5 IN COMPLEX WITH LPS
3V6FB:115-219; D:115-219; F:115-219; L:115-219CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6), UNBOUND
3V6OE:110-216; F:110-216LEPTIN RECEPTOR-ANTIBODY COMPLEX
3VFGL:108-214CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 3F8 FAB FRAGMENT THAT BINDS TO GD2 GANGLIOSIDE
3VG0L:110-215ANTIBODY FAB FRAGMENT
3VG9B:108-212CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 2.7 A RESOLUTION
3VGAB:108-212CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 3.1 A RESOLUTION
3VI3E:113-219; L:113-219CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
3ZDXF:108-214; L:108-214INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3ZKMD:112-217; L:112-217BACE2 FAB COMPLEX
3ZKND:112-217; L:112-217BACE2 FAB INHIBITOR COMPLEX
4A6YL:111-211CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3-NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
4AEHL:108-212CRYSTAL STRUCTURE OF THE ANTI-AAHI FAB9C2 ANTIBODY
4AEIL:113-218; M:113-217; N:113-217CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX
4AG4L:108-212CRYSTAL STRUCTURE OF A DDR1-FAB COMPLEX
4ALAL:108-212STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
4AMKL:111-212FAB FRAGMENT OF ANTIPORPHRIN ANTIBODY 13G10
4APQC:120-206CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE
4AT6B:111-212; D:111-212; F:111-212; I:111-212; K:111-212; L:111-212; N:111-212; P:111-212FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
4DGIL:108-213STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH HUMAN PRPC FRAGMENT 120-230
4DVBB:109-215; L:109-215THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112
4DW2L:108-214THE CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH THE FAB FRAGMENT OF MAB-112
4EBQL:111-214FAB STRUCTURE OF ANTI-VACCINIA VIRUS D8L ANTIGEN MOUSE IGG2A LA5
4EDXA:108-214; L:108-214NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM MOUSE MAB 911
4EI5C:115-202CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
4EI6A:115-203; B:116-243; C:115-202; D:116-243STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR
4ELKA:116-204; B:117-244; C:116-207; D:117-244CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR
4ETQB:111-213; L:111-213VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
4F15C:111-213; F:111-213; I:111-213; L:111-213MOLECULAR BASIS OF INFECTIVITY OF 2009 PANDEMIC H1N1 INFLUENZA A VIRUSES
4F2MB:108-213; D:108-211CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10
4F33A:107-212; C:107-212; E:107-212; G:107-212CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
4F37K:113-218; L:113-218STRUCTURE OF THE TETHERED N-TERMINUS OF ALZHEIMER'S DISEASE A PEPTIDE
4F3FA:107-212CRYSTAL STRUCTURE OF MSLN7-64 MORAB-009 FAB COMPLEX
4FFVC:107-210; L:107-210CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4, DPP-IV, CD26) IN COMPLEX WITH 11A19 FAB
4FFWC:107-210; L:107-206CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4, DPP-IV, CD26) IN COMPLEX WITH FAB + SITAGLIPTIN
4FG6D:107-211; F:107-211STRUCTURE OF ECCLC E148A MUTANT IN GLUTAMATE
4GAYB:108-212; L:108-211STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33
4GMSL:108-211; N:108-213CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ
4GMTL:108-213; M:108-213CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1
4GQ9L:110-212CHIKUNGUNYA VIRUS NEUTRALIZING ANTIBODY 9.8B FAB FRAGMENT
4H20L:108-214CRYSTAL STRUCTURE AND COMPUTATIONAL MODELING OF THE FAB FRAGMENT FROM THE PROTECTIVE ANTI-RICIN MONOCLONAL ANTIBODY RAC18
4H88L:108-213STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120-230
4HC1L:108-213; N:108-213CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3
4HDIA:113-217; L:113-219CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS
4HLZH:110-213; J:110-214; L:110-214CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4HXAL:108-214CRYSTAL STRUCTURE OF 13D9 FAB
4HXBL:108-214CRYSTAL STRUCTURE OF 6B9 FAB
4I9WD:107-211; F:107-211HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
4IRSA:186-279; C:115-203; D:113-240STRUCTURE OF THE MOUSE CD1D-PYRC-ALPHA-GALCER-INKT TCR COMPLEX
4J1UA:113-214; C:113-216; E:113-216CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
4JN1L:114-220AN ANTIDOTE FOR DABIGATRAN
4JN2A:114-220; L:114-220AN ANTIDOTE FOR DABIGATRAN
4JQIL:109-190STRUCTURE OF ACTIVE BETA-ARRESTIN1 BOUND TO A G PROTEIN-COUPLED RECEPTOR PHOSPHOPEPTIDE
4JR9L:107-211CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK
4JREC:107-211; L:107-211CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
4JZJB:114-219; L:114-219CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
4K23L:108-213STRUCTURE OF ANTI-UPAR FAB ATN-658
4K7PL:108-214GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
4K9EL:111-227CRYSTAL STRUCTURE OF KIT D4D5 FRAGMENT IN COMPLEX WITH ANTI-KIT ANTIBODIES FAB79D
4KI5F:108-214CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
4KJWD:107-211; F:107-211STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE
4KK5D:107-211; F:107-211STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE
4KK6D:107-211; F:107-211STRUCTURE OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE
4KK9D:107-211; F:107-211STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 2MM BROMIDE
4KKAD:107-211; F:107-211STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE
4KKBD:107-211; F:107-211STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE
4KKCD:107-211; F:107-211STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE
4KPHL:108-212; M:108-210STRUCTURE OF THE FAB FRAGMENT OF N62, A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN
4KQ4L:108-214CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357
4KRPC:108-211NANOBODY/VHH DOMAIN 9G8 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
4KUZL:113-216CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 4A5 FAB IN TRIGONAL FORM
4KVCL:108-2122H2 FAB FRAGMENT OF IMMATURE DENGUE VIRUS
4LEOB:114-219CRYSTAL STRUCTURE OF ANTI-HER3 FAB RG7116 IN COMPLEX WITH THE EXTRACELLULAR DOMAINS OF HUMAN HER3 (ERBB3)
4LEXL:113-217UNLIGANDED CRYSTAL STRUCTURE OF MAB7
4LF3A:107-214; D:107-214INHIBITORY MECHANISM OF AN ALLOSTERIC ANTIBODY TARGETING THE GLUCAGON RECEPTOR
4LVHC:111-210; F:111-210; I:111-210; L:111-210INSIGHT INTO HIGHLY CONSERVED H1 SUBTYPE-SPECIFIC EPITOPES IN INFLUENZA VIRUS HEMAGGLUTININ
4M43L:108-213CRYSTAL STRUCTURE OF ANTI-RABIES GLYCOPROTEIN FAB 523-11
4M61A:113-219; C:113-219CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
4M7JL:108-214CRYSTAL STRUCTURE OF S25-26 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO TRISACCHARIDE
4M7KL:114-220CRYSTAL STRUCTURE OF ANTI-TISSUE FACTOR ANTIBODY 10H10
4M7ZC:108-214; L:108-213UNLIGANDED 1 CRYSTAL STRUCTURE OF S25-26 FAB
4M93C:108-213; L:108-213UNLIGANDED 2 CRYSTAL STRUCTURE OF S25-26 FAB
4MA1C:108-214; F:108-214; L:108-214UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB
4MA7L:108-213CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE
4MA8L:108-213CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH CHLORPROMAZINE
4MAUL:112-216CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244
4NCC1:107-210; L:107-211NEUTRALIZING ANTIBODY TO MURINE NOROVIRUS
(-)
Murinae, homo sapiens [TaxId: 39107] (2)
4GW1A:108-212; C:108-213CQFD MEDITOPE
4GW5A:108-212; C:108-213CQYN MEDITOPE - CETUXIMAB FAB
(-)
Rabbit (Oryctolagus cuniculus) [TaxId: 9986] (1)
4HT1L:112-217HUMAN TWEAK IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY
(-)
Rhesus monkey (Macaca mulatta) [TaxId: 9544] (3)
3Q6GL:108-208; M:108-208CRYSTAL STRUCTURE OF FAB OF RHESUS MAB 2.5B SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
4KTDL:108-208FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY, GE136, FROM NON-HUMAN PRIMATE
4KTEL:108-208FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY, GE148, FROM NON-HUMAN PRIMATE